Profile
Marvin L.
Miller served as Executive Chairman at Onconova Therapeutics, Inc. from 2002 to 2006, Independent Director at Unigene Laboratories, Inc. from 2005 to 2011, Director at The National Center for Genome Resources, Director at rEVO Biologics, Inc. from 2002 to 2009, Vice President-Biotechnology Licensing at Wyeth Holdings LLC, Vice President at Johnson & Johnson from 1983 to 1986, and President at Nextran from 1994 to 2002.
He received an undergraduate degree from Philadelphia University and an MBA from the University of Wisconsin.
Former positions of Marvin L. Miller
Companies | Position | End |
---|---|---|
UNIGENE LABORATORIES INC | Director/Board Member | 2011-10-27 |
REVO BIOLOGICS INC | Director/Board Member | 2009-09-30 |
TRAWS PHARMA, INC. | Chairman | 2006-01-31 |
Nextran
Nextran Medical SpecialtiesHealth Technology Part of Baxter International, Inc., Nextran is an American company that develops and commercializes organ transplantation technologies. The company is based in NJ. Nextran was acquired by Baxter Healthcare Corp. from DNX Corp. on September 27, 1995 for $18 million. | President | 2001-12-31 |
JOHNSON & JOHNSON | Corporate Officer/Principal | 1985-12-31 |
Training of Marvin L. Miller
Philadelphia University | Undergraduate Degree |
University of Wisconsin | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
TRAWS PHARMA, INC. | Health Technology |
JOHNSON & JOHNSON | Health Technology |
Private companies | 6 |
---|---|
Unigene Laboratories, Inc.
Unigene Laboratories, Inc. Pharmaceuticals: OtherHealth Technology Unigene Laboratories, Inc. was a biopharmaceutical company, which engaged in the designing, delivering, manufacturing and development of peptide-based therapeutics. The company was founded by Jay Levy, Ronald S. Levy and Warren P. Levy on October 31, 1980 and was headquartered in Boonton, NJ. | Health Technology |
rEVO Biologics, Inc.
rEVO Biologics, Inc. BiotechnologyHealth Technology rEVO Biologics, Inc. engages in the development and commercialization of specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions. Its products include ATryn, which prevents blood clots during and after surgery and childbirth for patients with hereditary antithrombin deficiency. The company was founded in February 1993 and is headquartered in Framingham, MA. | Health Technology |
The National Center for Genome Resources
The National Center for Genome Resources Miscellaneous Commercial ServicesCommercial Services The National Center for Genome Resources operates as a non-profit research institute for applied software engineering and next-generation sequencing to solve the preeminent challenges of 21st century biology through collaborative research and services. Its capabilities include genome, transcriptome, methylome, ChIP, small RNA, and exome sequencing, with corresponding analytical capabilities. The company is headquartered in Santa Fe, NM. | Commercial Services |
Nextran
Nextran Medical SpecialtiesHealth Technology Part of Baxter International, Inc., Nextran is an American company that develops and commercializes organ transplantation technologies. The company is based in NJ. Nextran was acquired by Baxter Healthcare Corp. from DNX Corp. on September 27, 1995 for $18 million. | Health Technology |
Wyeth Holdings LLC
Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Wyeth Holdings LLC manufactures and distributes chemicals. The firm's chemical contains phosphate rock, calcium, lime, carbide and nitrogen which are used in fertilizers. The company was founded by Frank Washburn in 1907 and is headquartered in Wayne, NJ. | Process Industries |
Hoffman-LaRoche F & Co. AG
Hoffman-LaRoche F & Co. AG Miscellaneous Commercial ServicesCommercial Services Hoffman-LaRoche F & Co. AG is a Swiss company. | Commercial Services |
- Stock Market
- Insiders
- Marvin L. Miller